Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 62,745 | 28,671 | 66,194 | N/A | N/A |
Marketable Securities | 163,046 | 122,335 | 171,452 | N/A | N/A |
Receivables | 199,258 | 193,908 | 85,703 | N/A | N/A |
Inventories | 264,788 | 242,223 | 248,945 | N/A | N/A |
Income taxes - deferred | 50,508 | 96,791 | 86,900 | N/A | N/A |
Other current assets | 67,187 | 67,989 | 142,067 | 0 | 0 |
TOTAL | $842,064 | $786,976 | $831,345 | $N/A | $N/A |
Non-Current Assets | |||||
PPE Net | 214,126 | 199,472 | 194,487 | N/A | N/A |
Investments And Advances | 101,524 | 111,579 | 76,134 | 0 | 0 |
Intangibles | 1,441,652 | 1,448,142 | 1,444,545 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 33,387 | 0 | 0 |
TOTAL | $1,757,302 | $1,759,193 | $1,748,553 | $N/A | $N/A |
Total Assets | $2,599,366 | $2,546,169 | $2,579,898 | $N/A | $N/A |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 56,027 | 56,883 | 52,882 | N/A | N/A |
Accounts payable and accrued liabilities | 174,492 | 205,141 | 200,965 | 0 | 0 |
Other current liabilities | 6,708 | 7,658 | 7,658 | N/A | N/A |
TOTAL | $237,227 | $269,682 | $280,440 | $N/A | $N/A |
Non-Current Liabilities | |||||
Long Term Debt | 455,502 | 466,534 | 483,272 | N/A | N/A |
aiOther Non-Current Liabilities | 12,249 | 12,249 | 12,249 | 0 | 0 |
TOTAL | $671,577 | $682,808 | $751,489 | $N/A | $N/A |
Total Liabilities | $908,804 | $952,490 | $1,031,929 | $N/A | $N/A |
Shareholders' Equity | |||||
Shares Outstanding, K | 106,333 | 105,870 | N/A | N/A | N/A |
Common Shares | 351 | 349 | 348 | N/A | N/A |
Retained earnings | 835,394 | 769,149 | 706,693 | N/A | N/A |
Other shareholders' equity | 71,757 | 56,566 | 82,168 | 0 | 0 |
TOTAL | $1,690,562 | $1,593,679 | $1,547,969 | $N/A | $N/A |
Total Liabilities And Equity | $2,599,366 | $2,546,169 | $2,579,898 | $0 | $0 |